Introduction

55
Alkylating agents are ubiquitous. They are present in the environment (e.g. cigarette 56 smoke and fuel combustion), diet (e.g. presence of nitrosamines in food), or are 57 endogenously produced [1, 2] . Although generally in low concentrations, alkylating 58 agents may be mutagenic and carcinogenic [3] . Another source of human exposure to 59 alkylating agents is cancer chemotherapy [4] where several alkylating agents are used 60 due to their ability to induce extensive DNA damage and cell death. by the comet assay and % DNA in tails will be higher as the extent of MGMT inhibition 234 increases.
235
To test this hypothesis, Caco-2 cells -MMR-proficient -were treated with the was also evaluated by the TUNEL assay. As shown in Fig. 3 will be generated upon cell division. This new damage is recognized by the proteins of 330 the MMR pathway that, in attempting to repair the mismatch, generate SB in the DNA.
331
As long as O 6 meG remains in one of the DNA template strands, the MMR repair 332 process will be repeated, creating a "futile repair loop" that results in double-strand 333 breaks. Accumulation of SB will eventually induce cell death by apoptosis.
334
In this study, BG was used at a concentration that inhibited MGMT in Caco-2 cells, as
335
shown by western blot. When the concentration of BG was decreased, the expression of
336
MGMT at 72h was higher in a BG concentration-dependent manner. This effect was In order to test the specificity of this modified comet to detect SB originated by MMR 349 action on O 6 meG, a MMR deficient cell line (HCT116) was used. As expected, in
350
HCT116 cells, DNA damage remains similar to basal levels even in the presence of BG.
351
In MMR deficient cells the comet assay will not detect O 6 meG damages because they
352
will not be transformed into SB and therefore will be undetectable by the comet assay.
353
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